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Background and purpose   The use of hip arthroplasties is evi-
dently increasing, but there are few published data on the inci-
dence in young patients.
Methods We used data on total and resurfacing hip 
arthroplasties (THAs and RHAs) from the Finnish Arthroplasty 
Register and population data from Statistics Finland to analyze 
the incidences of THA and RHA in patients aged 30–59 years in 
Finland, for the period 1980 through 2007.
Results   The combined incidences of THAs and RHAs among 
30- to 59-year-old inhabitants increased from 9.5 per 105 inhabit-
ants in 1980 to 61 per 105 inhabitants in 2007. Initially, the inci-
dence of THA was higher in women than men, but since the mid-
90s the incidences were similar. The incidence increased in all age 
groups studied (30–39, 40–49, and 50–59 years) but the increase 
was 6-fold and 36-fold higher in the latter two groups than in the 
first. The incidence of THA was constant; the increased incidence 
of overall hip arthroplasty was due to the increasing number of 
RHAs performed.
Interpretation   We have found a steady increase in the 
incidence of hip arthroplasty in patients with primary hip 
osteoarthritis in Finland, with an accelerating trend in the past 
decade, due to an increase in the incidence of RHA. As the inci-
dence of hip osteoarthritis has not increased, the indications for 
hip arthroplasty appear to have become broader. 
 
75% of THAs are performed on elderly patients for painful 
osteoarthritis (OA); in younger patients (under 50–60 years), 
the proportion of OA diminishes to 42–54%. Most patients are 
women (Lucht 2000, Furnes et al. 2001, Puolakka et al. 2001, 
Malchau et al. 2002).
Several authors have reported an increasing incidence of 
treatment of OA with THA (Birrell et al. 1999, Ostendorf et 
al. 2002, Wells et al. 2002, Merx et al. 2003, Kurtz et al. 2005, 
2007), but only a few authors have reported the incidences 
for younger patients separately (Birrell et al. 1999, Ingvarsson 
et al. 1999). Resurfacing hip arthroplasty (RHA) is an option 
marketed for younger patients, though its value is still uncer-
tain (McGrory et al. 2009). 
We examined the changes in incidence of primary THA and 
RHA in young patients with OA in Finland between the years 
1980 and 2007.
Patients and methods
Inclusion criteria
All THAs and RHAs performed in patients aged 30–59 years 
with primary hip osteoarthritis who had been entered in the 
Finnish Arthroplasty Register between 1980 and 2007 were 
included (Table). Data concerning the Finnish population 
during the study period were obtained from Statistics Finland; 
we used the end-of-year population as an approximation of 
the population each year. The population data were divided 
into cohorts by age (30–39, 40–49, and 50–59 years) and sub-
groups according to sex.
Incidence of hip arthroplasty 
The general incidence is presented as the number of operations 
performed per 105 person years in Finnish inhabitants aged 
30–59 years. Incidence by sex is presented as the number of 
operations performed per 105 person years in men or women 
aged 30–59 years. The incidences by age group are presented 
as the number of operations performed per 105 person years in 
Finnish inhabitants aged 30–39 years, 40–49 years, and 50–59 
years.
All incidence calculations were done separately for THAs 
and RHAs.2  Acta Orthopaedica 2011; 82 (1): 1–5
Statistics
We analyzed the differences between every group for general 
incidence of THA and RHA, sex-specific incidence, and inci-
dence by age group by calculating incidence rate ratio (IRR) 
using Poisson regression. For each comparison, the IRR for 
annual increase in incidence was calculated first and the effect 
of the group was then calculated. The increase in IRR is pre-
sented as a percentage (e.g. IRR = 1.048 is shown as 4.8%) 
with 95% CI. The differences were considered to be statisti-
cally significant if p-values were less than 0.05 in a two-tailed 
test. We used STATA 8.2 statistical software (StataCorp, Col-
lege Station, TX).
Results
Patient characteristics
Between 1980 and 2007, 17,248 hip arthroplasties were per-
formed for primary osteoarthritis in patients aged less than 
60 years in Finland (Table). Of these operations, 8,159 (47%) 
were performed on women and 2,234 (13%) were RHAs. 
All RHAs were performed from 2001 through 2007. Median 
age at the time of surgery was 55 years (interquartile range: 
51–58).
General incidence
There was a 6-fold increase in the incidence of hip arthroplasty 
over the whole study period: the incidence increased from 9.5 
operations per 105 inhabitants in 1980 (in patients aged 30–59 
years) to 61 in 2007 (Figure 1). The peak incidence was noted 
in 2006 (62 per 105) but the decrease in the number of RHAs 
reduced the general incidence despite the steady growth in the 
number of THAs. The IRR for annual increase in general inci-
dence was 6.6% (CI: 6.3–6.8).
The incidence of THA grew steadily from 9.5 to 39 per 105 
during the period 1980–2007, with 858 THAs performed in 
2007. The IRR for annual increase in incidence of THA was 
4.5% (CI: 4.3–4.7). The incidence of RHA increased rapidly 
from 1.1 to 26 operations per 105 during 2001–2006 (Figure 
1), but the incidence decreased to 22 in 2007, with 484 RHAs 
performed in that year. The IRR for annual increase in inci-
dence of RHA was 37% (CI: 36–40).
Incidence by sex
In 1980, hip arthroplasties were performed 1.7 times more 
frequently in women than in men (11.9 vs. 7.1 per 105 inhabit-
ants) (Figure 2A). However, regarding whether there was any 
difference between the sexes, the IRR for increase in incidence 
of hip arthroplasty was 9.1% (CI: 5.9–12.4) higher in men than 
in women (p < 0.001). Given the IRR for annual increase in 
general incidence of 6.6% (see above), hip arthroplasties were 
performed 1.2 times more frequently in men than in women 
(67 vs. 56 per 105) in 2007.
There were no statistically significant differences in annual 
increase in the incidence of THA between men and women 
(IRR = 3.0%, CI: –1.0 to 5.9; p = 0.1) (Figure 2B). In con-
trast, the IRR for increase in incidence of RHA was 68% (CI: 
54–83) higher in men than in women (p < 0.001) (Figure 2C).
Incidence by age group
In all age groups, there appeared to be an increase in incidence 
of all hip arthroplasties—THAs and RHAs (Figure 3A). In the 
30–39-year age group, the IRR for annual increase in inci-
dence of hip arthroplasty was 5.2% (CI: 5.0–5.4). Between 
Hip arthroplasties in young patients (30–59 years of age) during 
1980–2007, according to type of hip arthroplasty, sex, and age 
group
  n % 
Patients aged 30–59 years (primary OA)  17,248  100
 THA  15,014  87
 RHA  2,234  13
Proportion of women (< 60 years)  8,159  47
 THA  7,335  43
 RHA  824  4.8
Age groups of the study population   17,248  100
  30–39 years of age  407  2.4
     THA  302  1.8
     RHA  105  0.6
  40–49 years of age  2,619  15
     THA  2,083  12
     RHA  536  3.1
  50–59 years of age  14,222  82
     THA  12,629  73
     RHA  1,593  9.2
  
THA: total hip arthroplasty; 
RHA: resurfacing hip arthroplasty. 
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Figure 1. General incidence of hip arthroplasty for primary osteoarthritis 
in young patients (30–59 years of age). Acta Orthopaedica 2011; 82 (1): 1–5  3
groups, the difference in IRR for increase in incidence of 
hip arthroplasty was 6-fold (614%, CI: 594–634; p < 0.001), 
i.e. any given incidence in the 30–39-year group was 6-fold 
higher in the 40–49-year group, and it was 36-fold higher in 
the 50–59-year group.
In THAs, the difference between groups was even more pro-
nounced, with a 7-fold increase in IRR for increase in inci-
dence of hip arthroplasty (690%, CI: 665–716; p < 0.001). The 
IRR for annual increase in incidence of THA was 3.2% (CI: 
2.9–3.4). In RHAs, there was also a marked 3-fold increase in 
IRR between groups (320%, CI: 298–343, p < 0.001).
Discussion
Our main finding was the steady annual increase in incidence 
of hip arthroplasty in young patients over the period 1980–
2007, with an accelerating trend over the past decade (Figure 
1). The incidence of THA had a constant annual increase of 
4.5%, and the acceleration appeared to be triggered by RHA 
quickly becoming popular since its inception in 2001. In Fin-
land, the overall hip arthroplasty (THA and RHA) incidences 
have grown more quickly in men than in women. In the age 
groups 30–39, 40–49, and 50–59 years, the increase in inci-
dence has been more pronounced in the latter 2 groups, the 
most substantial growth being in the last group.
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Figure 2. A. Incidence of all hip arthroplasties for primary osteoarthritis in young patients (30–59 years of age), by sex. The increase in incidence 
during 1980–2007 was greater in men than in women (p < 0.001). B. Incidence of total hip arthroplasty (THA) for primary osteoarthritis in young 
patients (30–59 years of age), by sex. C. Incidence of resurfacing hip arthroplasty (RHA) for primary osteoarthritis in young patients (30–59 years 
of age), by sex. The increase in incidence during 2001–2007 was greater in men than in women (p < 0.001).
Figure 3. A. Incidence of all hip arthroplasties for primary osteoarthritis in young patients (30–59 years of age), by age group. B. Incidence of total 
hip arthroplasty (THA) for primary osteoarthritis in young patients (30–59 years of age), by age group. C. Incidence of resurfacing hip arthroplasty 
(RHA) for primary osteoarthritis in young patients (30–59 years of age), by age group.
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Registry-based studies have certain limitations. The Finnish 
Arthroplasty Register covered 90% of hip implants in the year 
1995, and after that the coverage increased to 98% (Mäkelä 
et al. 2008). This might explain a minor part of the increase 
shown in our study. Because of the accurate civil registry of 
Statistics Finland and the low level of illegal immigration in 
Finland, the population data can be assumed to correspond to 
the actual population. Nevertheless, limitations in the accu-
racy of the data and in conclusions drawn may result from 
inconsistencies or errors in the diagnostic coding entered into 
the registry (Ingvarsson et al. 1999, Pedersen et al. 2004) 
There have been few studies in which separate incidences 
have been reported for young patients. Kurtz et al. (2005) 
found a 50% increase in incidence in THA in the USA during 
1990–2002, and, although not directly stated, an approximate 
annual increase in incidence of 4.5% in the youngest-studied 
group (45–64 years) can be calculated from their article, which 
coincides with our results. In a study from NHS hospitals in 
the UK in 1996 (Dixon et al. 2004), incidences for THA in 
women in the age groups < 39, 40–49, and 50–59 years were 
2.1, 16, and 115 per 105 individuals. In men, the correspond-
ing incidences were 1.4, 13, and 90 per 105. In our study, the 
incidence of THA in women was higher than in men only until 
the mid-1990s. Presently, the incidence of THA is similar in 
men and women, and the incidence of all hip arthroplasties is 
20% higher in men (Figure 2). Another study using the same 
UK NHS hospital data from 1996 showed total incidence rates 
of 12 and 189 per 105 for the age groups 0–54 and 55–64 years 
(Birrell et al. 1999). The authors also projected the need for 
THA in the UK—but only for patients aged over 55 years—
using estimated changes in demographic data until 2026. The 
projected overall increase in number of THAs was 24% for 
the period 1996–2006 in the youngest group of 55–64-year-
old patients with OA. During the same time period in our 
study, the increase in number of hip arthroplasties in the 
oldest group (50–59 years) was 42% and 121% for THAs and 
all hip arthroplasties, respectively. However, any direct com-
parison between these studies is impossible, because the age 
groups were not the same, registration differed considerably, 
and demographic changes (immigration, birth rates, etc) can 
be divergent. We cautiously conclude that our increasing inci-
dence rates support the direction of the projected changes in 
hip arthroplasty numbers in the study by Birrell et al. (1999).
Wells et al. (2002) reported an increase in the incidence 
of THA from 48 to 84 per 105 in patients with primary 
osteoarthritis in the province of South Australia between 1988 
and 1998. Between 1994 and 1998 in the total Australian pop-
ulation, the incidence rates increased from 51 to 61 per 105. 
The article does not provide actual incidence rates in numbers 
for different age groups but the annual increase in incidence of 
THA was 5% in all age groups (Wells et al. 2002). 
We have shown an obvious increase in the incidence of 
hip arthoplasty in young patients. The finding is apparent in 
both sexes and even in the youngest age groups. Demographic 
changes alone give no explanation to the changes in incidence. 
Furthermore, the prevalence of hip OA and hip symptoms has 
remained unchanged in Finland and other countries over ear-
lier decades (Danielsson and Lindberg 1997, Heliövaara et al. 
2007). Orthopedic surgeons are ultimately responsible for the 
increased rate, as they do the operations. Have we changed 
our approach due to pressure from patients, industry, or new 
clinical data? Our modern way of life possibly requires higher 
functional ability in both work and leisure. Younger patients 
may opt for elective operations at an earlier stage, with 
milder symptoms, than previously. Prosthesis manufacturers 
are eager to develop and market new concepts and designs, 
including novel THA bearings and RHA. This marketing takes 
place both indirectly through community- or internet-based 
advertising, or directly through their relationships with ortho-
pedic surgeons. Good long-term results in terms of implant 
survivorship of THA in older age groups have encouraged 
surgeons to broaden the indications for THA to younger and 
more active patients. Whatever the underlying reasons for the 
observed increase in the incidence of hip arthroplasty, the 
advent of RHA has had a substantial impact on the incidence 
of hip arthroplasty.
In conclusion, age- and sex-standardized incidences of THA 
and RHA in young patients with primary osteoarthritis have 
increased in Finland. This phenomenon has been especially 
strong during the current decade. There is no single explana-
tory factor for this growth. Some of the increase in incidence 
may be explained by hospital volume or geographic location 
of the patients. In general, the observed growth is so rapid and 
high, that given the lack of information on long-term outcome 
of hip arthroplasties in younger patients and the recent con-
cerns about metal-on-metal hip arthroplasties (Langton et al. 
2010), we should really be worried about a rapid increase in 
revision hip arthroplasties in the near future. Future long-term 
results of hip arthroplasty in younger age groups will reveal 
whether or not our current policy of widespread use of hip 
arthroplasty in younger patients is wise.
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